An artificial intelligence-enabled health data mining start-up, established six months ago by former chief executive of genome sequencing giant Beijing Genomic Institute (BGI), is raising RMB700 million (US$106 million) series A round at a valuation of RMB5 billion (US$760 million). Shanghai-listed Chinese cell and gene engineering firm Vcanbio Cell & Gene Engineering Corporation, Ltd. disclosed […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.